Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3092 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2003-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9904f8e6e1578bf8109c18ed625bb28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efb5065a9dc3087a0b404a8442647975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a034d4c0772546e2b14fdbaaea5dc7ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02bc67a6a3697d20052b5821e295ebca |
publicationDate |
2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7183388-B2 |
titleOfInvention |
Anti-MUC-1 single chain antibodies for tumor targeting |
abstract |
This invention provides novel antibodies that specifically bind to the cancer antigen MUC-1. The antibodies are useful targeting moieties for specifically directing imaging agents and various therapeutic moieties to a cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9650426-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011123442-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8748379-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8518405-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010233732-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016037644-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10273308-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014140174-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019224275-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9937269-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022079211-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9766242-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009117119-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9090698-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10775382-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012047317-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9512423-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11554181-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9110066-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018069289-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010006508-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014057074-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9081019-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9845362-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-202102396-D0 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2839860-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785385-B2 |
priorityDate |
2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |